Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

Cell | 2009

The mTORC1 and mTORC2 pathways regulate cell growth, proliferation, and survival. We identify DEPTOR as an mTOR-interacting protein whose expression is negatively regulated by mTORC1 and mTORC2. Loss of DEPTOR activates S6K1, Akt, and SGK1, promotes cell growth and survival, and activates mTORC1 and mTORC2 kinase activities. DEPTOR overexpression suppresses S6K1 but, by relieving feedback inhibition from mTORC1 to PI3K signaling, activates Akt. Consistent with many human cancers having activated mTORC1 and mTORC2 pathways, DEPTOR expression is low in most cancers. Surprisingly, DEPTOR is highly overexpressed in a subset of multiple myelomas harboring cyclin D1/D3 or c-MAF/MAFB translocations. In these cells, high DEPTOR expression is necessary to maintain PI3K and Akt activation and a reduction in DEPTOR levels leads to apoptosis. Thus, we identify a novel mTOR-interacting protein whose deregulated overexpression in multiple myeloma cells represents a mechanism for activating PI3K/Akt signaling and promoting cell survival.

Pubmed ID: 19446321 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI47389
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI047389-07
  • Agency: NCI NIH HHS, United States
    Id: R01 CA103866-03
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI047389-08
  • Agency: Intramural NIH HHS, United States
  • Agency: NCI NIH HHS, United States
    Id: R01 CA129105
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI047389-09
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI047389
  • Agency: NCI NIH HHS, United States
    Id: R01 CA103866
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI047389-10
  • Agency: NCI NIH HHS, United States
    Id: R01 CA103866-02
  • Agency: NCI NIH HHS, United States
    Id: R01 CA103866-05
  • Agency: NCI NIH HHS, United States
    Id: R01 CA103866-04
  • Agency: NCI NIH HHS, United States
    Id: R01 CA103866-01
  • Agency: NCI NIH HHS, United States
    Id: R01 CA129105-03

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Motif Mutation Analysis for Regulatory Genomic Elements (tool)

RRID:SCR_021902

Software package that integrates genome wide genetic variation with epigenetic data to identify collaborative transcription factor pairs. Optimized to work with chromatin accessibility assays such as ATAC-seq or DNase I hypersensitivity, as well as transcription factor binding data collected by ChIP-seq. Used to identify combinations of cell type specific transcription factors while simultaneously interpreting functional effects of non-coding genetic variation.

View all literature mentions